My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 715

    1.

    Treatment of type 2 diabetes with combined therapy: what are the pros and cons?

    Massi-Benedetti M, Orsini-Federici M.

    Diabetes Care. 2008 Feb;31 Suppl 2:S131-5. Review.PMID: 18227473 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin therapy in type 2 diabetes.

    Mudaliar S, Edelman SV.

    Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.PMID: 11727406 [PubMed - indexed for MEDLINE]Related articles

    3.

    Type II diabetes mellitus.

    Edelman SV.

    Adv Intern Med. 1998;43:449-500. Review.PMID: 9506190 [PubMed - indexed for MEDLINE]Related articles

    4.

    Advances in oral therapy for type 2 diabetes.

    Davis SN.

    Postgrad Med. 2000 May 15;107(6 Suppl Key):16-20. Review.PMID: 19667506 [PubMed - indexed for MEDLINE]Related articles

    5.

    Managing type 2 diabetes: going beyond glycemic control.

    Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO.

    J Manag Care Pharm. 2008 Jun;14(5 Suppl B):s2-19.PMID: 18597582 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Protection of pancreatic beta-cells: is it feasible?

    Bonora E.

    Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. Review.PMID: 18096375 [PubMed - indexed for MEDLINE]Related articles

    7.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.

    Braunstein S.

    Clin Ther. 2003 Jul;25(7):1895-917. Review.PMID: 12946541 [PubMed - indexed for MEDLINE]Related articles

    9.

    Addition of insulin to oral therapy in patients with type 2 diabetes.

    Nelson SE, Palumbo PJ.

    Am J Med Sci. 2006 May;331(5):257-63. Review.PMID: 16702795 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain]

    Hermann LS, Melander A.

    Lakartidningen. 1999 Dec 15;96(50):5616-9. Review. Swedish. PMID: 10643226 [PubMed - indexed for MEDLINE]Related articles

    11.

    Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes.

    Bermúdez V, Cano R, Cano C, Bermúdez F, Leal E, Acosta K, Mengual E, Arraiz N, Briceño C, Gómez J, Bustamante M, Aparicio D, Cabrera M, Valdelamar L, Rodriguez M, Manuel V, Hernández R.

    Am J Ther. 2008 Jul-Aug;15(4):409-16.PMID: 18645347 [PubMed - indexed for MEDLINE]Related articles

    12.

    Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.

    Vinik A.

    Clin Ther. 2007;29 Spec No:1236-53. Review.PMID: 18046925 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pioglitazone and sulfonylureas: effectively treating type 2 diabetes.

    Hanefeld M.

    Int J Clin Pract Suppl. 2007 Jun;(153):20-7. Review.PMID: 17594390 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.

    Stafford JM, Elasy T.

    Vasc Health Risk Manag. 2007;3(4):503-10. Review.PMID: 17969380 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin analogs or premixed insulin analogs in combination with oral agents for treatment of type 2 diabetes.

    Levy P.

    MedGenMed. 2007 Apr 16;9(2):12. Review.PMID: 17955068 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Fate of the beta-cell in the pathophysiology of type 2 diabetes.

    Campbell RK.

    J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S10-5. Review.PMID: 19801360 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [Towards a tripple oral therapy in the pharmacological treatment of type 2 diabetes?]

    Scheen AJ.

    Rev Med Liege. 2005 May-Jun;60(5-6):414-8. Review. French. PMID: 16035303 [PubMed - indexed for MEDLINE]Related articles

    18.

    Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.

    Smiley D, Umpierrez G.

    Expert Opin Pharmacother. 2007 Jun;8(9):1353-64. Review.PMID: 17563269 [PubMed - indexed for MEDLINE]Related articles

    19.

    beta-cell function and anti-diabetic pharmacotherapy.

    Del Prato S, Bianchi C, Marchetti P.

    Diabetes Metab Res Rev. 2007 Oct;23(7):518-27. Review.PMID: 17883249 [PubMed - indexed for MEDLINE]Related articles

    20.

    Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes.

    Raskin P.

    Diabetes Metab Res Rev. 2008 Jan-Feb;24(1):3-13. Review.PMID: 17968971 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity